Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS (RMU), RMP, MCPS (Family Medicine)
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS (GOLD MEDALIST), MRCP (London, UK), Diploma Internal Medicine, Diploma Geriatric Medicine, MRCGP (London, UK)
Internal Medicine Specialist
MBBS (GOLD MEDALIST), MRCP (London, UK), Diploma Internal Medicine, Diploma Geriatric Medicine, MRCGP (London, UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S. , F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Pulmonologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Pulmanology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures